Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

The distal hinge of the reactive site loop and its proximity: a target to modulate plasminogen activator inhibitor-1 activity.

Bijnens AP, Gils A, Stassen JM, Komissarov AA, Knockaert I, Brouwers E, Shore JD, Declerck PJ.

J Biol Chem. 2001 Nov 30;276(48):44912-8. Epub 2001 Sep 14.

3.

Elucidation of the binding regions of PAI-1 neutralizing antibodies using chimeric variants of human and rat PAI-1.

Bijnens AP, Ngo TH, Gils A, Dewaele J, Knockaert I, Stassen JM, Declerck PJ.

Thromb Haemost. 2001 May;85(5):866-74.

PMID:
11372681
4.
5.
7.
8.

Importance of N-terminal residues in plasminogen activator inhibitor 1 on its antibody induced latency transition.

Ngo TH, Zhou Y, Stassen JM, Declerck PJ.

Thromb Haemost. 2002 Aug;88(2):288-93.

PMID:
12195702
9.

Elucidation of a novel epitope of a substrate-inducing monoclonal antibody against the serpin PAI-1.

Naessens D, Gils A, Compernolle G, Declerck PJ.

J Thromb Haemost. 2003 May;1(5):1028-33.

10.

Function-stabilizing mechanism of plasminogen activator inhibitor type 1 induced upon binding to alpha1-acid glycoprotein.

Smolarczyk K, Gils A, Boncela J, Declerck PJ, Cierniewski CS.

Biochemistry. 2005 Sep 20;44(37):12384-90.

PMID:
16156651
12.

A peptide accelerating the conversion of plasminogen activator inhibitor-1 to an inactive latent state.

Mathiasen L, Dupont DM, Christensen A, Blouse GE, Jensen JK, Gils A, Declerck PJ, Wind T, Andreasen PA.

Mol Pharmacol. 2008 Sep;74(3):641-53. doi: 10.1124/mol.108.046417. Epub 2008 Jun 17.

13.

Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1.

Madison EL, Goldsmith EJ, Gerard RD, Gething MJ, Sambrook JF, Bassel-Duby RS.

Proc Natl Acad Sci U S A. 1990 May;87(9):3530-3.

14.

Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein.

Andersen OM, Petersen HH, Jacobsen C, Moestrup SK, Etzerodt M, Andreasen PA, Thøgersen HC.

Biochem J. 2001 Jul 1;357(Pt 1):289-96.

16.

Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.

Björquist P, Ehnebom J, Inghardt T, Hansson L, Lindberg M, Linschoten M, Strömqvist M, Deinum J.

Biochemistry. 1998 Feb 3;37(5):1227-34.

PMID:
9477948
17.

Structural determinants in the stability of the serpin/proteinase complex.

De Taeye B, Verbeke K, Compernolle G, Biesemans W, Gils A, Declerck PJ.

Biochem Biophys Res Commun. 2003 Aug 1;307(3):529-34.

PMID:
12893254
18.
19.

Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1.

Kjøller L, Martensen PM, Sottrup-Jensen L, Justesen J, Rodenburg KW, Andreasen PA.

Eur J Biochem. 1996 Oct 1;241(1):38-46.

Items per page

Supplemental Content

Write to the Help Desk